Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)

Autor:	Wedgewood
Zdroj:	Business Wire (English). 09/18/2024.
Abstrakt:	Today, Wedgewood announces the addition of molnupiravir to its formulary. Originally developed for human viral infections, including COVID-19, molnupiravir has emerged as a promising option for both first- and second-line therapy of Feline Infectious Peritonitis (FIP). This often-fatal disease affects an estimated 15,000 US cats each year, posing a significant concern for veterinarians and cat owners alike. [ABSTRACT FROM PUBLISHER]
Databáze:	Regional Business News
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.